# EDGAR Filing Document

**Accession Number:** 0001534261
**File Stem:** 0000919574-25-005423
**Filing Date:** 2025-8
**Character Count:** 19464
**Document Hash:** f9cd3d38657b5e9f930d4eb3ff34dda2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000919574-25-005423.hdr.sgml**: 20250829

**ACCESSION NUMBER**: 0000919574-25-005423

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250829

**EFFECTIVENESS DATE**: 20250829

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Casdin Capital, LLC
- **CENTRAL INDEX KEY:** 0001534261

**ORGANIZATION NAME:**
- **EIN:** 800752351
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-17113
- **FILM NUMBER:** 251281778

**BUSINESS ADDRESS:**
- **STREET 1:** 1350 AVENUE OF THE AMERICAS
- **STREET 2:** SUITE 2600
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10019
- **BUSINESS PHONE:** 212.300.5575

**MAIL ADDRESS:**
- **STREET 1:** 1350 AVENUE OF THE AMERICAS
- **STREET 2:** SUITE 2600
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10019

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001534261

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** Casdin Capital, LLC

**Address:** 1350 AVENUE OF THE AMERICAS, NEW YORK, NY 10019

**Telephone number:** 212-897-5430

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-17113

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                          | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                                                                     | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| BioLife Solutions, Inc.                 | 09062W204 | 08/01/2024     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |        8707165 |                0 | FOR         |                                  8707165 | FOR                         |  |
| Moderna, Inc.                           | 60770K107 | 04/30/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         225000 |                0 | AGAINST     |                                   225000 | AGAINST                     |  |
| Alnylam Pharmaceuticals, Inc.           | 02043Q107 | 05/08/2025     | To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers.                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |          39582 |                0 | FOR         |                                    39582 | FOR                         |  |
| Syndax Pharmaceuticals, Inc.            | 87164F105 | 05/14/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2025 proxy statement.                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |          91349 |                0 | FOR         |                                    91349 | FOR                         |  |
| BeiGene Ltd.                            | 07725L102 | 05/21/2025     | THAT, on a non-binding, advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement, be and is hereby approved.                                                                                  | SECTION 14A SAY-ON-PAY VOTES |          40000 |                0 | AGAINST     |                                    40000 | AGAINST                     |  |
| Illumina, Inc.                          | 452327109 | 05/21/2025     | To approve, on an advisory basis, the compensation of the named executive officers as disclosed in the Proxy Statement.                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |         388735 |                0 | FOR         |                                   388735 | FOR                         |  |
| Teladoc Health, Inc.                    | 87918A105 | 05/22/2025     | Approve, on an advisory basis, the compensation of Teladoc Health's named executive officers.                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |         118017 |                0 | AGAINST     |                                   118017 | AGAINST                     |  |
| Verastem, Inc.                          | 92337C203 | 05/22/2025     | To approve an advisory vote on the compensation of the named executive officers.                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |          72202 |                0 | FOR         |                                    72202 | FOR                         |  |
| GE Healthcare Technologies, Inc.        | 36266G107 | 05/28/2025     | Approval of our named executive officers' compensation in an advisory vote.                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |          50095 |                0 | FOR         |                                    50095 | FOR                         |  |
| Denali Therapeutics Inc.                | 24823R105 | 06/03/2025     | Advisory vote on executive compensation                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |         890000 |                0 | FOR         |                                   890000 | FOR                         |  |
| Beam Therapeutics Inc.                  | 07373V105 | 06/04/2025     | Approve, on an advisory basis, the compensation of our named executive officers.                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         201205 |                0 | FOR         |                                   201205 | FOR                         |  |
| Pacific Biosciences of California, Inc. | 69404D108 | 06/04/2025     | To approve, on an advisory basis, the compensation of our named executive officers.                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |         723767 |                0 | AGAINST     |                                   723767 | AGAINST                     |  |
| Sarepta Therapeutics, Inc.              | 803607100 | 06/05/2025     | ADVISORY VOTE TO APPROVE, ON A NON-BINDING BASIS, NAMED EXECUTIVE OFFICER COMPENSATION                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |         180462 |                0 | FOR         |                                   180462 | FOR                         |  |
| Verve Therapeutics, Inc.                | 92539P101 | 06/05/2025     | Approval, on an advisory basis, of the compensation paid to our named executive officers.                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |        1738237 |                0 | FOR         |                                  1738237 | FOR                         |  |
| Relay Therapeutics, Inc.                | 75943R102 | 06/06/2025     | To consider and act upon an advisory vote on the compensation of our named executive officers;                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |        5467195 |                0 | FOR         |                                  5467195 | FOR                         |  |
| Avidity Biosciences, Inc.               | 05370A108 | 06/10/2025     | To consider and vote upon, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission; and                  | SECTION 14A SAY-ON-PAY VOTES |         250992 |                0 | AGAINST     |                                   250992 | AGAINST                     |  |
| Codexis, Inc.                           | 192005106 | 06/10/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |        2944598 |                0 | FOR         |                                  2944598 | FOR                         |  |
| Intellia Therapeutics, Inc.             | 45826J105 | 06/11/2025     | Approval, on a non-binding advisory basis, of the compensation of our named executive officers ("NEOS").                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         469463 |                0 | AGAINST     |                                   469463 | AGAINST                     |  |
| Intellia Therapeutics, Inc.             | 45826J105 | 06/11/2025     | A non-binding advisory vote on the frequency of future non-binding advisory votes on the compensation of our NEOS.                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |         469463 |                0 | ONE YEAR    |                                   469463 | FOR                         |  |
| Exact Sciences Corporation              | 30063P105 | 06/12/2025     | To approve, on an advisory basis, the compensation of our named executive officers.                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |          36770 |                0 | FOR         |                                    36770 | FOR                         |  |
| Ginkgo Bioworks Holdings, Inc.          | 37611X209 | 06/12/2025     | Advisory vote to approve executive compensation.                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |          55405 |                0 | FOR         |                                    55405 | FOR                         |  |
| Hims  Hers Health, Inc.                 | 433000106 | 06/12/2025     | Advisory approval of the Company's executive compensation.                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |         150614 |                0 | AGAINST     |                                   150614 | AGAINST                     |  |
| Neurogene, Inc.                         | 64135M105 | 06/12/2025     | To approve on an an (non-binding) basis the compensation of the Company's named executive officers.                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |         418159 |                0 | FOR         |                                   418159 | FOR                         |  |
| Solid Biosciences Inc.                  | 83422E204 | 06/12/2025     | The approval of an advisory vote on executive compensation.                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |         300000 |                0 | AGAINST     |                                   300000 | AGAINST                     |  |
| Veracyte, Inc.                          | 92337F107 | 06/17/2025     | The approval, on a non-binding advisory basis, of the compensation of our named executive officers, as disclosed in our proxy statement.                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         276308 |                0 | FOR         |                                   276308 | FOR                         |  |
| Veracyte, Inc.                          | 92337F107 | 06/17/2025     | The selection, on a non-binding advisory basis, whether future advisory votes on the compensation paid by us to our named executive officers should be held every one, two or three years.                                                           | SECTION 14A SAY-ON-PAY VOTES |         276308 |                0 | ONE YEAR    |                                   276308 | FOR                         |  |
| Agios Pharmaceuticals, Inc.             | 00847X104 | 06/18/2025     | To vote, on an advisory basis, to approve the compensation paid to our named executive officers.                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |          25000 |                0 | FOR         |                                    25000 | FOR                         |  |
| Blueprint Medicines Corporation         | 09627Y109 | 06/18/2025     | Approval of a non-binding advisory vote on the compensation paid to our named executive officers.                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |         146378 |                0 | FOR         |                                   146378 | FOR                         |  |
| Guardant Health, Inc.                   | 40131M109 | 06/18/2025     | Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation.                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |          29781 |                0 | FOR         |                                    29781 | FOR                         |  |
| Recursion Pharmaceuticals, Inc.         | 75629V104 | 06/18/2025     | Advisory vote to approve executive compensation as disclosed in the 2025 Proxy Statement.                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |         165323 |                0 | FOR         |                                   165323 | FOR                         |  |
| Standard BioTools Inc.                  | 34385P108 | 06/18/2025     | To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement.                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |       76075636 |                0 | FOR         |                                 76075636 | FOR                         |  |
| Structure Therapeutics Inc.             | 86366E106 | 06/23/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |         376868 |                0 | FOR         |                                   376868 | FOR                         |  |
| Structure Therapeutics Inc.             | 86366E106 | 06/23/2025     | To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of the Company's named executive officers.                                                                                              | SECTION 14A SAY-ON-PAY VOTES |         376868 |                0 | ONE YEAR    |                                   376868 | FOR                         |  |
| Revolution Medicines, Inc.              | 76155X100 | 06/26/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"). | SECTION 14A SAY-ON-PAY VOTES |        1277463 |                0 | FOR         |                                  1277463 | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** Casdin Capital, LLC

**By (Signature):** Steve Giordano

**By (Printed Signature):** Steve Giordano

**By (Title):** General Counsel

**Date:** 08/29/2025